반려동물 건강 시장 : 동물별, 적응증별, 유형별, 최종 용도별, 유통 채널별 - 세계 예측(2025-2030년)

The Companion Animal Health Market was valued at USD 33.76 billion in 2023, expected to reach USD 39.72 billion in 2024, and is projected to grow at a CAGR of 17.73%, to USD 105.92 billion by 2030.

The companion animal health market is a dynamic sector focusing on the well-being of pets like cats, dogs, birds, and small mammals through preventive, therapeutic, and diagnostic solutions. This sector's scope encompasses pharmaceuticals, vaccines, nutritional supplements, diagnostic tests, and veterinary services designed to enhance pet longevity and quality of life. The necessity for these offerings is driven by increasing pet adoption rates and the humanization of pets, where pet owners demand higher standards of care. Applications range from preventive healthcare measures to treatment of chronic and acute diseases, ensuring comprehensive animal care. End-use sectors primarily include veterinary clinics, animal hospitals, and households. Growth in this market is fueled by technological advancements like telemedicine, wearable technology for pets, and the rising prevalence of zoonotic diseases necessitating vigilant monitoring and health management of companion animals. Notable opportunities arise from the growing aging pet population, increasing demand for insurance, and advances in genetic testing, which are areas ripe for market entry and development. Companies can leverage these opportunities by investing in technology and infrastructure to support advanced diagnostics and personalized medicine for pets. However, challenges persist, including stringent regulatory environments, high costs associated with healthcare products and services, and limited access to veterinary care in certain regions. Addressing such limitations requires robust R&D initiatives to improve product affordability and compliance. Innovation can focus on developing multifunctional products that serve preventive and therapeutic purposes and integrating AI and data analytics for enhanced disease surveillance and management. The market is competitive but promising, with scope for expansion augmented by rising pet ownership trends worldwide. Strategic partnerships, focus on pet owner education, and diversified product lines that cater to specific pet health needs are crucial for seizing market potential and driving business growth in this sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Companion Animal Health Market

The Companion Animal Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing initiatives by government and animal welfare associations
  • Technological advancements in the field of animal healthcare
  • Changing the perception of the consumers toward pet health and longer life expectancy for companion animal
  • Increasing disposable incomes and pet owners afford to spend more on pet healthcare
  • Increasing online shopping and home delivery is driving the product sale
• Market Restraints
  • Increase in cheap counterfeit drugs
  • Lack of infrastructure, funding, and standardization
• Market Opportunities
  • Increase in cheap counterfeit drugs
  • Lack of infrastructure, funding, and standardization
• Market Challenges
  • Prohibition on the use of antibiotics and antimicrobials in animal feed in many countries,
  • High cost associated with animal testing and veterinary in developing countries

Porter's Five Forces: A Strategic Tool for Navigating the Companion Animal Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Companion Animal Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Companion Animal Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Companion Animal Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Companion Animal Health Market

A detailed market share analysis in the Companion Animal Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Companion Animal Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Companion Animal Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Companion Animal Health Market

A strategic analysis of the Companion Animal Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Health Market, highlighting leading vendors and their innovative profiles. These include Alcami Corporation, B. Braun Melsungen AG, Bayer AG, Bioiberica S.A.U., Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Cozmix Inc., Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Elanco US, Inc., Eli Lilly and Company, IDEXX Laboratories, Inc., Medtronic PLC, Merck & Co., Inc., Nutreco N.V., Perrigo Company PLC, Vetoquinol SA, Virbac SA, and Zoetis, Inc..

Market Segmentation & Coverage

This research report categorizes the Companion Animal Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Animal, market is studied across Cats, Dogs, and Horses.
• Based on Indication, market is studied across Behavioral Disorders, Dental Diseases, Dermatologic Diseases, Infectious Diseases, and Orthopedic Diseases.
• Based on Type, market is studied across Medicinal Additive Feed, Nutritional Feed Additives, Pharmaceuticals, and Vaccines. The Medicinal Additive Feed is further studied across Amino Acids, Minerals, and Vitamins. The Nutritional Feed Additives is further studied across Enzymes, Feed Acidifiers, Hormones, Immune Modulators, and Prebiotics & Probiotics. The Pharmaceuticals is further studied across Anti-Inflammatory, Antibiotics, Ectoparasiticides, and Endoparasiticides.
• Based on End-Use, market is studied across Point-of-care Testing or In-house Testing and Veterinary Hospitals & Clinics.
• Based on Distribution Channel, market is studied across E-commerce, Hospital Pharmacies, and Retail.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing initiatives by government and animal welfare associations
    • 5.1.1.2. Technological advancements in the field of animal healthcare
    • 5.1.1.3. Changing the perception of the consumers toward pet health and longer life expectancy for companion animal
    • 5.1.1.4. Increasing disposable incomes and pet owners afford to spend more on pet healthcare
    • 5.1.1.5. Increasing online shopping and home delivery is driving the product sale
  • 5.1.2. Restraints
    • 5.1.2.1. Increase in cheap counterfeit drugs
    • 5.1.2.2. Lack of infrastructure, funding, and standardization
  • 5.1.3. Opportunities
    • 5.1.3.1. Increase in cheap counterfeit drugs
    • 5.1.3.2. Lack of infrastructure, funding, and standardization
  • 5.1.4. Challenges
    • 5.1.4.1. Prohibition on the use of antibiotics and antimicrobials in animal feed in many countries,
    • 5.1.4.2. High cost associated with animal testing and veterinary in developing countries
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Companion Animal Health Market, by Animal

• 6.1. Introduction
• 6.2. Cats
• 6.3. Dogs
• 6.4. Horses

7. Companion Animal Health Market, by Indication

• 7.1. Introduction
• 7.2. Behavioral Disorders
• 7.3. Dental Diseases
• 7.4. Dermatologic Diseases
• 7.5. Infectious Diseases
• 7.6. Orthopedic Diseases

8. Companion Animal Health Market, by Type

• 8.1. Introduction
• 8.2. Medicinal Additive Feed
  • 8.2.1. Amino Acids
  • 8.2.2. Minerals
  • 8.2.3. Vitamins
• 8.3. Nutritional Feed Additives
  • 8.3.1. Enzymes
  • 8.3.2. Feed Acidifiers
  • 8.3.3. Hormones
  • 8.3.4. Immune Modulators
  • 8.3.5. Prebiotics & Probiotics
• 8.4. Pharmaceuticals
  • 8.4.1. Anti-Inflammatory
  • 8.4.2. Antibiotics
  • 8.4.3. Ectoparasiticides
  • 8.4.4. Endoparasiticides
• 8.5. Vaccines

9. Companion Animal Health Market, by End-Use

• 9.1. Introduction
• 9.2. Point-of-care Testing or In-house Testing
• 9.3. Veterinary Hospitals & Clinics

10. Companion Animal Health Market, by Distribution Channel

• 10.1. Introduction
• 10.2. E-commerce
• 10.3. Hospital Pharmacies
• 10.4. Retail

11. Americas Companion Animal Health Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Companion Animal Health Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Companion Animal Health Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alcami Corporation
• 2. B. Braun Melsungen AG
• 3. Bayer AG
• 4. Bioiberica S.A.U.
• 5. Boehringer Ingelheim GmbH
• 6. Ceva Sante Animale S.A.
• 7. Cozmix Inc.
• 8. Dechra Pharmaceuticals PLC
• 9. Elanco Animal Health Incorporated
• 10. Elanco US, Inc.
• 11. Eli Lilly and Company
• 12. IDEXX Laboratories, Inc.
• 13. Medtronic PLC
• 14. Merck & Co., Inc.
• 15. Nutreco N.V.
• 16. Perrigo Company PLC
• 17. Vetoquinol SA
• 18. Virbac SA
• 19. Zoetis, Inc.